Search & Analyze

Acutaas Chemicals Ltd.

4,010.00+28.45 (+0.71%)

BSE · 30 Oct, 4:01 PM

: ₹32,770.14 Cr
: 74.62
: 59,479
: ₹4,023.25 - ₹3,910.70
: ₹4,031.85 - ₹1,571.20

Acutaas Chemicals Ltd. (ACUTAAS) share price closed at ₹4,010.00 on the BSE on Friday, October 30, 2026, up by 0.71% from its of ₹3,981.55. In that session ACUTAAS reached a of 4,023.25 and of 3,910.70. The for the session was 3,986.95. The stands at 3,282.66 and is at 2,818.38. Looking at , the stock ended the session in Uptrend.

Stock Overview

₹3,968.55

₹3,981.55

₹3,986.95

₹3,282.66

Price 22.16% above

₹2,818.38

Price 42.28% above

Key Fundamentals

: 32,770.14 Cr₹32.77 Thousand Crore
: 53.64
: 74.62
: 17.64
: 226.87
: 645.91 Cr₹645.91 Crore
: 0.06 %
Sector
Industry: Pharmaceuticals & Drugs
: 24.08
: 0.02

Industry Comparison

Ratio	Company	Sector
	74.62	44.77
	0.02	0.20
	17.64	4.61
	3.82	1.81
	0.06 %	0.11 %
Operating Margin	35.87 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,778.25	38.91	4,26,661.74	0.90	1,995.07	-36.16%	16,198.71	11.88%	19.11
DIVI'S LAB. DIVISLAB	9,715.00	88.17	2,57,902.73	0.31	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,635.15	83.01	1,76,306.21	0.82	534.00	-9.64%	4,979.00	50.79%	19.27
LAURUSLABS LAURUSLABS	2,392.00	96.46	1,29,242.68	0.08	436.19	124.27%	2,206.37	33.44%	18.20
ZYDUSLIFE ZYDUSLIFE	1,244.00	27.50	1,24,089.48	0.08	990.20	-34.90%	8,017.00	21.96%	21.39
DR.REDDY'S DRREDDY	1,350.20	40.25	1,12,698.53	0.59	913.20	-31.69%	8,697.80	-1.48%	13.75
CIPLA LTD. CIPLA	1,380.00	38.48	1,11,488.55	0.94	851.51	-37.08%	7,403.93	-2.44%	16.00
Acutaas Chemicals Ltd. ACUTAAS	4,010.00	74.62	32,770.14	0.06	123.14	71.37%	436.92	42.69%	32.42

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	176.67	246.73	274.99	308.48	207.24	306.20	393.18	432.75	329.68	436.92
Expenses	147.15	197.80	206.32	223.53	156.33	210.87	242.53	249.24	216.60	260.95
	29.52	48.93	68.67	84.96	50.91	95.32	150.66	183.51	113.07	175.97
	16.71%	19.83%	24.97%	27.54%	24.57%	31.13%	38.32%	42.41%	34.30%	40.27%
	1.04	8.44	1.67	5.78	15.94	9.84	4.70	11.11	1.80	5.10
Interest	4.43	0.50	0.69	0.60	0.64	0.58	0.86	1.19	1.14	1.02
	6.18	6.83	6.32	7.30	8.13	8.40	9.83	9.63	9.82	12.69
	19.96	50.04	63.33	82.83	58.08	96.18	144.67	183.80	103.91	167.36
	26.38%	24.93%	28.25%	24.29%	24.22%	25.29%	26.58%	26.94%	27.83%	26.42%
	13.94	37.33	44.95	62.48	44.29	72.24	107.96	131.76	74.26	125.17
	3.41	9.12	10.98	7.63	5.41	8.82	13.19	16.09	9.07	15.29

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	520.14	616.73	717.47	1,006.88	1,339.37
	520.14	616.73	717.47	1,006.88	1,339.37
EXPENDITURE :
Increase/Decrease in Stock	-9.50	-14.96	-28.48	-17.63	-29.00
Raw Material Consumed	282.33	345.85	440.17	569.81	594.96
Power & Fuel Cost	21.40	22.28	25.82	30.12	37.36
Employee Cost	41.37	48.84	63.11	83.66	117.57
Other Manufacturing Expenses	49.66	46.98	47.35	51.77	66.88
General and Administration Expenses	7.30	9.93	12.97	19.23	30.66
Selling and Distribution Expenses	19.92	26.49	19.88	29.63	31.31
Miscellaneous Expenses	2.49	8.71	8.15	8.22	9.23
	414.96	494.13	588.98	774.80	858.97
Operating Profit (Excl OI)	105.18	122.61	128.49	232.07	480.40
	2.76	4.32	7.49	16.93	41.59
	107.94	126.93	135.98	249.00	521.98
Interest	6.41	2.41	5.94	6.22	3.27
PBDT	101.53	124.51	130.04	242.78	518.71
	10.08	12.34	16.06	26.62	35.99
Profit Before Taxation & Exceptional Items	91.45	112.17	113.99	216.16	482.73
Exceptional Income / Expenses			-32.08
	91.45	112.17	81.90	216.16	482.73
Provision for Tax	19.50	28.88	33.19	55.75	126.36
	71.95	83.29	48.71	160.42	356.37
Extra items				0.00	0.00
Minority Interest			-5.94	-1.70	-0.11
Consolidated Net Profit	71.95	83.29	42.77	158.71	356.26
Adjustments to PAT		0.05
Profit Balance B/F	131.28	203.00	275.64	307.12	453.43
Appropriations	203.23	286.34	318.41	465.84	809.69
Equity Dividend %	30.00%	30.00%	30.00%	30.00%	50.00%
	19.75	22.86	11.60	19.39	43.51
Adjusted EPS	9.87	11.43	5.80	9.69	43.51

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	36.44	36.44	36.88	40.93	40.94
Share Warrants & Outstandings			2.31	0.11	3.11
Total Reserves	485.84	557.52	634.81	1,268.59	1,609.51
Reserve excluding Revaluation Reserve	485.84	557.52	634.81	1,268.59	1,609.51
Revaluation reserve			0.00	0.00
	522.27	593.96	674.00	1,309.63	1,653.56
Minority Interest			8.76	10.45	57.19
Secured Loans	0.59	0.63	113.64
Deferred Tax Assets / Liabilities	6.26	8.83	13.02	19.63	28.71
Other Long Term Liabilities				4.75	9.11
Long Term Provisions	0.44	0.68	1.32	2.55	4.59
Total Non-Current Liabilities	7.29	10.13	127.98	26.93	42.40
Trade Payables	118.42	142.05	134.61	156.05	153.91
Other Current Liabilities	4.88	6.64	64.78	13.48	12.44
Short Term Borrowings		2.77	72.59	8.18	26.49
Short Term Provisions	6.02	11.39	13.20	24.54	37.98
Total Current Liabilities	129.32	162.85	285.17	202.25	230.81
Total Liabilities	658.88	766.94	1,095.90	1,549.26	1,983.96
Gross Block	231.14	297.69	481.95	651.64	862.09
Less: Accumulated Depreciation	26.60	38.74	54.79	81.25	117.23
	204.53	258.95	427.16	570.39	744.86
	1.89	25.52	125.42	130.28	332.32
Non Current Investments	1.71	1.65	0.20	0.20	0.20
Long Term Investment	1.71	1.65	0.20	0.20	0.20
Long Term Loans & Advances	14.23	17.20	48.59	55.88	24.42
Other Non Current Assets	5.87	2.21	1.23	0.88	0.91
Total Non-Current Assets	229.31	309.81	602.60	757.63	1,102.69
Inventories	112.17	119.17	156.73	179.94	231.32
Sundry Debtors	163.70	230.26	206.35	290.49	362.56
Cash and Bank	99.55	58.67	53.31	248.93	224.83
Other Current Assets	11.09	7.95	4.44	3.07	5.30
Short Term Loans and Advances	43.05	41.08	72.47	69.20	57.24
Total Current Assets	429.57	457.13	493.30	791.64	881.27
Net Current Assets (Including Current Investments)	300.25	294.28	208.13	589.39	650.46
Total Assets	658.88	766.94	1,095.90	1,549.26	1,983.96
	2.70	2.70	2.07	15.38	17.25
Total Debt	0.84	3.60	216.65	8.18	26.49
	143.34	163.01	182.13	159.95	201.59
Adjusted Book Value	71.67	81.50	91.06	79.98	201.59

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	91.45	112.17	81.90	216.16	482.73
Adjustment	13.64	14.09	49.79	18.92	14.13
Changes In working Capital	-94.21	-36.28	17.82	-70.01	-93.11
Cash Flow after changes in Working Capital	10.88	89.98	149.52	165.08	403.74
Cash Flow from Operating Activities	-11.93	65.53	125.17	118.34	292.17
Cash Flow from Investing Activities	-120.72	-33.04	-365.39	-223.94	-265.94
Cash Flow from Financing Activitie	140.26	-12.25	239.36	261.12	4.10
Net Cash Inflow / Outflow	7.61	20.24	-0.86	155.52	30.33
Opening Cash & Cash Equivalents	2.68	10.30	30.53	29.70	185.22
Effect of Foreign Exchange Fluctuations			0.03
Closing Cash & Cash Equivalent	10.30	30.53	29.70	185.22	215.55

Ratios

Valuation

74.62

17.64

50.27

20.58

53.64

226.87

Profitability

24.08

32.42

20.17

35.87

26.61

Leverage & Liquidity

0.02

3.82

148.71

Returns

0.06

0.76

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	35.98	35.97	35.96	35.96	32.66	32.66	32.66	32.66	32.66	32.66
	27.73	33.80	35.77	34.80	39.33	39.45	38.38	39.09	41.18	42.03
	36.29	30.23	28.27	29.23	28.01	27.89	28.96	28.24	26.16	25.31
	64.02	64.03	64.04	64.04	67.34	67.34	67.34	67.34	67.34	67.34
No. of Shareholders	90,987	93,394	95,756	1,14,060	1,19,890	1,08,664	1,10,363	1,12,939	1,25,569	1,47,026

Mutual Funds Invested(165)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 91 active funds hold 13.60% in Acutaas Chemicals Ltd., contributing to ₹3.65K Cr of holdings

Fund				As of
MO Motilal Oswal Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	356.26	2.65	10,86,350	Sep '26
SB SBI Healthcare Opportunities Fund - Growth - Direct PlanPharma & Health Care	295.15	5.03	9,00,000	Sep '26
KO Kotak Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	271.20	0.89	8,26,974	Sep '26
KO Kotak Multi Asset Allocation Fund - Growth - Direct PlanHybrid - Multi Asset Allocation	148.68	0.98	4,53,378	Sep '26
UT UTI Small Cap Fund - Growth - Direct PlanSmall cap Fund	131.59	2.52	4,01,249	Sep '26
IT ITI Small Cap Fund - Growth - Direct PlanSmall cap Fund	130.07	3.55	3,96,614	Sep '26
KO Kotak Balanced Advantage Fund - Growth - Direct PlanHybrid - Balanced Advantage	126.59	0.76	3,86,016	Sep '26
SB SBI Small Cap Fund - Growth - Direct PlanSmall cap Fund	121.85	0.30	3,71,566	Sep '26
HD HDFC Pharma and Healthcare Fund - Growth - Direct PlanPharma & Health Care	111.17	3.18	3,39,010	Sep '26
IP ICICI Prudential Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	110.74	0.59	3,37,693	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-22	Board Meeting	Quarterly Results
2026-08-28	AGM
2026-07-20	Board Meeting	Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares
2026-06-02	Virendra Nath Mishra	Market	Sell	119
2026-06-02	Virendra Nath Mishra	Market	Sell	40,000
2026-06-02	Virendra Nath Mishra	Market	Buy	119

Sector Overview

HealthcarePharmaceuticals & Drugs

Acutaas Chemicals Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

9 members across the board and senior leadership

Ekta K Srivastava

Company Secretary & Compliance Officer

—

Nareshkumar Patel

Chairman & Managing Director

₹6.42 Cr

Mar '26

Chetankumar Vaghasia

Whole Time Director

₹6.42 Cr

Mar '26

Virendra Nath Mishra

Whole Time Director

₹1.95 Cr

Mar '26

Ram Mohan Lokhande

Whole Time Director

₹1.88 Cr

Mar '26

Girikrishna Maniar

Non Executive Independent Director

₹20.00 L

Mar '26

Hetal Gandhi

Non Executive Independent Director

₹20.00 L

Mar '26

Richa Goyal

Non Executive Independent Director

₹10.00 L

Mar '26

Anita Bandyopadhyay

Non Executive Independent Director

₹10.00 L

Mar '26

ACUTAAS Latest News

News

10 of 10 articles

EQUITY19 Oct 2026 · 12:05

Acutaas Chemicals climbs on completing acquisition of 100% stake in Enchem Ami Organics

Enchem Ami Organics has become a direct wholly-owned subsidiary of the company

COMPANY19 Oct 2026 · 11:59

Acutaas Chemicals completes acquisition of 100% stake in Enchem Ami Organics

Enchem Ami Organics has become a direct wholly-owned subsidiary of the company

COMPANY25 Sept 2026 · 12:42

Acutaas Chemicals gets nod to acquire 100% stake in Enchem Ami Organics

The Board of Directors of the company has at its meeting held on September 24, 2026, approved the same

COMPANY4 Sept 2026 · 14:29

Acutaas Chemicals inaugurates pilot plant in Surat

The pilot plant will support the R&D for new product trials and validations

EQUITY28 Aug 2026 · 13:07

Acutaas Chemicals informs about press release

COMPANY28 Aug 2026 · 11:51

Acutaas Chemicals’ arm inaugurates semiconductor chemicals manufacturing plant in South Korea

The plant was completed within 11 months of its groundbreaking on September 29, 2025

COMPANY24 Aug 2026 · 12:30

Acutaas Chemicals gets nod for Rs 212 crore capital expenditure plan

The project targets a production capacity of up to 81,000 metric tonnes per annum for new electronic grade chemicals

EQUITY18 Aug 2026 · 17:33

Acutaas Chemicals informs about updates

EQUITY20 Jul 2026 · 17:13

Acutaas Chemicals informs about conference call

EQUITY20 Jul 2026 · 13:28

Acutaas Chemicals submits board meeting intimation

Acutaas Chemicals Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(165)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

ACUTAAS Latest News

News